Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma

Table 5 Comparison of ¹⁸F-FDG PET and ¹⁸F-FAPI PET in post treatment patients

Patient No	Primary treatment	Local recurrence detection		Distant metastasis detection		Additional finding (¹⁸F-FAPI PET)
Patient No	Primary treatment	¹⁸F-FDG PET	¹⁸F-FAPI PET	¹⁸F-FDG PET	¹⁸F-FAPI PET	Additional finding (¹⁸F-FAPI PET)
3	surgery	-	+	-	-	Local recurrence
32	systemic therapy	+	+	-	-	-
33	TACE	+	+	-	-	-
45	TACE and RFA	-	+	-	-	Local recurrence
48	surgery and systemic therapy	+	+	+	+	-
49	TACE	-	+	+	+	Local recurrence
50	surgery and systemic therapy	-	+	-	-	Local recurrence
58	RFA and systemic therapy	+	+	-	-	-

¹⁸F Fluorine 18, FDG fluorodeoxyglucose, FAPI fibroblast activation protein inhibitor, PET positron emission tomography, TNM Tumor Node Metastasis, TACE transcatheter arterial chemoembolization, RFA radiofrequency ablation

ISSN: 1470-7330